NCT00862680

4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis

4D PET/CT Imaging in Lung and Colorectal Cancer With Liver Metastasis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 75 (actual)
• Sponsor: M.D. Anderson Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This trial studies how well 4 dimensional (D) positron emission tomography/computed tomography (PET/CT) works in diagnosing participants with lung or colorectal cancer that has spread to the liver and lung. Diagnostic procedures, such as PET/CT, may help find and diagnose disease and find out how far the disease has spread. But the motions made by breathing can reduce the image quality of the scan. Adjusting the scanner to 4D may allow for more breathing motion may improve the quality of the PET/CT images.

Detailed description

PRIMARY OBJECTIVES: I. Study the impact of 4D positron emission tomography/computed tomography (PET/CT) imaging on the evaluation and staging of lung and colorectal cancer. OUTLINE: Participants undergo 4D PET/CT scan over up to 12 minutes.

Conditions

• Metastatic Malignant Neoplasm in the Liver
• Metastatic Malignant Neoplasm in the Lung
• Stage IV Colorectal Cancer AJCC v8
• Stage IV Lung Cancer AJCC v8
• Stage IVA Colorectal Cancer AJCC v8
• Stage IVA Lung Cancer AJCC v8
• Stage IVB Colorectal Cancer AJCC v8
• Stage IVB Lung Cancer AJCC v8
• Stage IVC Colorectal Cancer AJCC v8

Interventions

Type	Name	Description
PROCEDURE	4-Dimensional Computed Tomography	Undergo 4D PET/CT
PROCEDURE	4D PET Scan	Undergo 4D PET/CT scan

Timeline

• Start date: 2009-03-12
• Primary completion: 2019-04-28
• Completion: 2019-04-28
• First posted: 2009-03-17
• Last updated: 2020-04-14

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study